Pages that link to "Q41197639"
Jump to navigation
Jump to search
The following pages link to Topiramate: a new antiepileptic drug for refractory epilepsy (Q41197639):
Displaying 9 items.
- Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study (Q36496058) (← links)
- Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach (Q38154625) (← links)
- Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release (Q38812405) (← links)
- Emerging Treatments in Eating Disorders (Q39155123) (← links)
- Postmarketing experience with topiramate and cognition (Q42660595) (← links)
- Topiramate selectively decreases intracortical excitability in human motor cortex (Q44169556) (← links)
- Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization (Q48384000) (← links)
- Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. (Q51906679) (← links)
- Using Topiramate in Patients with Epilepsy: Practical Aspects (Q77100624) (← links)